Biology not behaviour could explain reduced risk of HIV infection for circumcised men

March 25, 2004

Research from India published in this week's issue of THE LANCET suggests that circumcised men could be over six times less likely than uncircumcised men to acquire HIV infection. The study also shows how the explanation for this decreased risk in circumcised men is likely to be biological rather than behavioural, with thin tissue in the foreskin being the likely target for viral activity.

Previous research has shown that circumcised men have a lower risk of HIV-1 infection than uncircumcised men. Laboratory findings have suggested that the foreskin is enriched with HIV-1 target cells. However, other research has suggested that circumcision could be an indicator for low-risk sexual behaviour.

Robert C Bollinger and colleagues from Johns Hopkins University Medical School, USA, and the National Aids Research Institute, Pune, India, observed how uncircumcised men attending sexually transmitted infection clinics in India were over six times more likely to acquire HIV infection than men who had been circumcised. All men were HIV-negative when first assessed; most men were assessed three times after initial assessment for around a year. No protective effect of circumcision against herpes simplex virus type 2, syphilis, or gonorrhoea was found.

Dr Bollinger comments: "These data confirm previous findings that male circumcision reduces the risk of HIV-1 acquisition. This analysis expands on earlier studies by including laboratory-defined incident STIs as outcomes in the analysis, as well as by including risk behaviour to control for other potential differences between circumcised and uncircumcised men. A unique and important finding from this study was a highly significant and specific protective effect of male circumcision on the risk of HIV-1 acquisition. Our data failed to show a significant protective effect of circumcision on the risk of the other STIs. These epidemiological data lend support to the hypothesis that male circumcision protects against HIV-1 infection primarily due to removal of the foreskin, which contains a high density of HIV-1-specific cellular targets, including CD4+ T-lymphocytes and Langerhans' cells, which are easily accessible to the virus through the thin layer of keratin overlying the inner mucosa".
-end-
Contact: Mr John Lazarou, Senior Media Relations Representative, Office of Corporate Communications, Johns Hopkins University School of Medicine, 550 N Broadway, Room 1100, Baltimore, Maryland 21205, USA; T) 410-502-8902; F) 410-955-4452; E) jlazaro1@jhmi.edu

Lancet

Related HIV Articles from Brightsurf:

BEAT-HIV Delaney collaboratory issues recommendations measuring persistent HIV reservoirs
Spearheaded by Wistar scientists, top worldwide HIV researchers from the BEAT-HIV Martin Delaney Collaboratory to Cure HIV-1 Infection by Combination Immunotherapy (BEAT-HIV Collaboratory) compiled the first comprehensive set of recommendations on how to best measure the size of persistent HIV reservoirs during cure-directed clinical studies.

The Lancet HIV: Study suggests a second patient has been cured of HIV
A study of the second HIV patient to undergo successful stem cell transplantation from donors with a HIV-resistant gene, finds that there was no active viral infection in the patient's blood 30 months after they stopped anti-retroviral therapy, according to a case report published in The Lancet HIV journal and presented at CROI (Conference on Retroviruses and Opportunistic Infections).

Children with HIV score below HIV-negative peers in cognitive, motor function tests
Children who acquired HIV in utero or during birth or breastfeeding did not perform as well as their peers who do not have HIV on tests measuring cognitive ability, motor function and attention, according to a report published online today in Clinical Infectious Diseases.

Efforts to end the HIV epidemic must not ignore people already living with HIV
Efforts to prevent new HIV transmissions in the US must be accompanied by addressing HIV-associated comorbidities to improve the health of people already living with HIV, NIH experts assert in the third of a series of JAMA commentaries.

The Lancet HIV: Severe anti-LGBT legislations associated with lower testing and awareness of HIV in African countries
This first systematic review to investigate HIV testing, treatment and viral suppression in men who have sex with men in Africa finds that among the most recent studies (conducted after 2011) only half of men have been tested for HIV in the past 12 months.

The Lancet HIV: Tenfold increase in number of adolescents on HIV treatment in South Africa since 2010, but many still untreated
A new study of more than 700,000 one to 19-year olds being treated for HIV infection suggests a ten-fold increase in the number of adolescents aged 15 to 19 receiving HIV treatment in South Africa, according to results published in The Lancet HIV journal.

Starting HIV treatment in ERs may be key to ending HIV spread worldwide
In a follow-up study conducted in South Africa, Johns Hopkins Medicine researchers say they have evidence that hospital emergency departments (EDs) worldwide may be key strategic settings for curbing the spread of HIV infections in hard-to-reach populations if the EDs jump-start treatment and case management as well as diagnosis of the disease.

NIH HIV experts prioritize research to achieve sustained ART-free HIV remission
Achieving sustained remission of HIV without life-long antiretroviral therapy (ART) is a top HIV research priority, according to a new commentary in JAMA by experts at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.

The Lancet HIV: PrEP implementation is associated with a rapid decline in new HIV infections
Study from Australia is the first to evaluate a population-level roll-out of pre-exposure prophylaxis (PrEP) in men who have sex with men.

Researchers date 'hibernating' HIV strains, advancing BC's leadership in HIV cure research
Researchers have developed a novel way for dating 'hibernating' HIV strains, in an advancement for HIV cure research.

Read More: HIV News and HIV Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.